000 01500 a2200409 4500
005 20250513115039.0
264 0 _c19970424
008 199704s 0 0 eng d
022 _a0041-1345
024 7 _a10.1016/s0041-1345(96)00670-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWaldman, W J
245 0 0 _aCMV as an exacerbating agent in transplant vascular sclerosis: potential immune-mediated mechanisms modelled in vitro.
_h[electronic resource]
260 _bTransplantation proceedings
_c
300 _a1545-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aArteriosclerosis
_xetiology
650 0 4 _aCells, Cultured
650 0 4 _aCytomegalovirus
_xphysiology
650 0 4 _aCytomegalovirus Infections
_xcomplications
650 0 4 _aEndothelium, Vascular
_ximmunology
650 0 4 _aFemale
650 0 4 _aHLA-DR Antigens
_xbiosynthesis
650 0 4 _aHumans
650 0 4 _aIntercellular Adhesion Molecule-1
_xbiosynthesis
650 0 4 _aMale
650 0 4 _aPostoperative Complications
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aT-Lymphocytes, Cytotoxic
_ximmunology
650 0 4 _aTransplantation, Homologous
_ximmunology
700 1 _aAdams, P W
700 1 _aKnight, D A
700 1 _aSedmak, D D
773 0 _tTransplantation proceedings
_gvol. 29
_gno. 1-2
_gp. 1545-6
856 4 0 _uhttps://doi.org/10.1016/s0041-1345(96)00670-7
_zAvailable from publisher's website
999 _c9104944
_d9104944